Literature DB >> 23490391

Identification of specific regions in hepatitis C virus core, NS2 and NS5A that genetically interact with p7 and co-ordinate infectious virus production.

H Gouklani1, C Beyer, H Drummer, E J Gowans, H J Netter, G Haqshenas.   

Abstract

The p7 protein of hepatitis C virus (HCV) is a small, integral membrane protein that plays a critical role in virus replication. Recently, we reported two intergenotypic JFH1 chimeric viruses encoding the partial or full-length p7 protein of the HCV-A strain of genotype 1b (GT1b; Virology; 2007; 360:134). In this study, we determined the consensus sequences of the entire polyprotein coding regions of the wild-type JFH1 and the revertant chimeric viruses and identified predominant amino acid substitutions in core (K74M), NS2 (T23N, H99P) and NS5A (D251G). Forward genetic analysis demonstrated that all single mutations restored the infectivity of the defective chimeric genomes suggesting that the infectious virus production involves the association of p7 with specific regions in core, NS2 and NS5A. In addition, it was demonstrated that the NS2 T23N facilitated the generation of infectious intergenotypic chimeric virus encoding p7 from GT6 of HCV.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23490391     DOI: 10.1111/jvh.12004

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  10 in total

1.  Transverse relaxation dispersion of the p7 membrane channel from hepatitis C virus reveals conformational breathing.

Authors:  Jyoti Dev; Sven Brüschweiler; Bo Ouyang; James J Chou
Journal:  J Biomol NMR       Date:  2015-02-28       Impact factor: 2.835

2.  Characterization of the Determinants of NS2-3-Independent Virion Morphogenesis of Pestiviruses.

Authors:  O Klemens; D Dubrau; N Tautz
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

3.  The intraviral protein interaction network of hepatitis C virus.

Authors:  Nicole Hagen; Karen Bayer; Kathrin Rösch; Michael Schindler
Journal:  Mol Cell Proteomics       Date:  2014-05-05       Impact factor: 5.911

4.  The Unusual Transmembrane Partition of the Hexameric Channel of the Hepatitis C Virus.

Authors:  Wen Chen; Jyoti Dev; Julija Mezhyrova; Liqiang Pan; Alessandro Piai; James J Chou
Journal:  Structure       Date:  2018-03-15       Impact factor: 5.006

5.  Three-dimensional structure and interaction studies of hepatitis C virus p7 in 1,2-dihexanoyl-sn-glycero-3-phosphocholine by solution nuclear magnetic resonance.

Authors:  Gabriel A Cook; Lindsay A Dawson; Ye Tian; Stanley J Opella
Journal:  Biochemistry       Date:  2013-07-24       Impact factor: 3.162

6.  Cooperation between the Hepatitis C Virus p7 and NS5B Proteins Enhances Virion Infectivity.

Authors:  Mounavya Aligeti; Allison Roder; Stacy M Horner
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

Review 7.  The minimalist architectures of viroporins and their therapeutic implications.

Authors:  Bo OuYang; James J Chou
Journal:  Biochim Biophys Acta       Date:  2013-09-18

8.  A positive-strand RNA virus uses alternative protein-protein interactions within a viral protease/cofactor complex to switch between RNA replication and virion morphogenesis.

Authors:  Danilo Dubrau; M Alejandra Tortorici; Félix A Rey; Norbert Tautz
Journal:  PLoS Pathog       Date:  2017-02-02       Impact factor: 6.823

9.  The amino-terminus of the hepatitis C virus (HCV) p7 viroporin and its cleavage from glycoprotein E2-p7 precursor determine specific infectivity and secretion levels of HCV particle types.

Authors:  Solène Denolly; Chloé Mialon; Thomas Bourlet; Fouzia Amirache; François Penin; Brett Lindenbach; Bertrand Boson; François-Loïc Cosset
Journal:  PLoS Pathog       Date:  2017-12-18       Impact factor: 6.823

Review 10.  Approaches to hepatitis C treatment and cure using NS5A inhibitors.

Authors:  James J Kohler; James H Nettles; Franck Amblard; Selwyn J Hurwitz; Leda Bassit; Richard A Stanton; Maryam Ehteshami; Raymond F Schinazi
Journal:  Infect Drug Resist       Date:  2014-03-05       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.